Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

NCT01631552

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +78 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center Newark, Delaware, United States
  • MD Anderson Cancer Center Orlando (UF Health Cancer Center) Orlando, Florida, United States
View Trial Details
Completed

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

NCT00978250

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +21 more
Locations
  • University of California, Davis Davis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Medical Group South Pasadena, California, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details

Related conditions